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Abstract
Background: Sepsis sequelae include critical illness polyneuropathy, myopathy, wasting, neurocognitive deficits,
post-traumatic stress disorder, depression and chronic pain. Little is known howlong-term sequelae following
hospital discharge are treated. The aim of our study is to determine the effect of a primary care-based, long-term
program on health-related quality of life in sepsis survivors.
Methods/Design: In a two-armed randomized multicenter interventional study, patients after sepsis (n = 290) will
be assessed at 6, 12 and 24 months. Patients are eligible if severe sepsis or septic shock (ICD-10), at least two criteria
of systemic inflammatory response syndrome (SIRS), at least one organ dysfunction and sufficient cognitive capacity
are present. The intervention comprises 1) discharge management, 2) training of general practitioners and patients
in evidence-based care for sepsis sequelae and 3) telephone monitoring of patients. At six months, we expect an
improved primary outcome (health-related quality of life/SF-36) and improved secondary outcomes such as costs,
mortality, clinical-, psycho-social- and process-of-care measures in the intervention group compared to the control
group.
Discussion: This study evaluates a primary care-based, long-term program for patients after severe sepsis. Study
results may add evidence for improved sepsis care management. General practitioners may contribute efficiently to
sepsis aftercare.
Trial registration: U1111-1119-6345. DRKS00000741, CCT-NAPN-20875 (25 February 2011).
Keywords: Severe sepsis, Sequelae, Critical illness, Primary health care, Aftercare
Background
Sepsis is a worldwide major health concern with increas-
ing incidence [1]. About 85,000 patients a year survive se-
vere sepsis or septic shock [2,3] in Germany. Main sepsis
sequelae include critical illness polyneuropathy/myopathy,
cognitive deficits and chronic pain, all symptoms of neur-
onal degeneration [4-7]. In addition, post-traumatic stress
disorder (PTSD) and depression are prevalent after stress
exposure in the intensive care unit (ICU) [8,9].
Thus, the majority of sepsis survivors suffer from a
considerable deficit in physical and psycho-social func-
tions [10], showing a reduced health-related quality of
life [11-13]. In addition to the individual burden, sepsis
causes significant health economic costs, about four to
seven billion Euro/year for Germany alone, including in-
direct costs due to loss-of-work [3].
At least, sepsis sequelae are considered to be generic
for symptoms after critical illness in general [13], which
is of even more clinical and socioeconomic relevance.
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To improve care for long-term conditions, coordin-
ation of the fragmented process by structured interven-
tions is effective [14]. The British National Institute for
Health and Clinical Excellence’s guideline Rehabilitation
after critical illness states that ‘evidence is often missing
and only incorporates aftercare for up to three months’
[15]. Based on a current systematic review, few follow-
up interventions have been published [16]. Of these,
Hacking et al. observed functional improvement of am-
putations associated with sepsis by an intensive rehabili-
tation program [17]. Jones et al. presented an increase of
physical function in 126 critical illness patients who
were provided a self-help manual for six months [18]. A
British pilot study of Jackson et al., with 21 critical care
patients, showed a non-significant reduction of post-
traumatic symptoms using an in-house, multifaceted
telemedicine program [19]. In contrast, a home-based
rehabilitation program for eight weeks did not lead to
better health-related quality of life or to better physical
function in Australian critical illness patients [20]. A
nurse-based translational pilot program that incorpo-
rated case management for patients with chronic critical
illness was not effective for clinical or psycho-social
outcomes [21,22].
After ICU care and hospital-based rehabilitation, most
sepsis survivors receive aftercare from their primary
care physician, as with most chronically ill patients. This
setting is characterized by a long-lasting doctor-patient
relationship, with all health services being coordinated
[23]. Primary care-based interventions to improve sepsis
sequelae are still rare [16].
This study will evaluate the effects of a primary care-
based intervention to improve aftercare for sepsis survivors.
Methods/Design
Aim of the study
This study will evaluate whether health-related quality of
life (SF-36) and further clinical, psycho-social, process-
of-care outcomes and costs of sepsis survivors will be
improved by a primary care-based, sepsis-specific after-
care program.
Scientific hypothesis
After six months, the intervention group will show
an improved primary outcome (SF-36) compared to pa-
tients with usual care in the control group.
Study design
The study is a multicenter, prospective, two-armed ran-
domized controlled trial. Since the intervention could
compromise educational elements for primary care physi-
cians and patients, we are not able to perform a blinded
intervention. GPs are allocated only to one patient - either
to the control or intervention group.
Sample size
A wide range of effect sizes is found in comparable stud-
ies. Jackson et al. [19] reported that for executive func-
tioning ability a Cohen’s d =1.1 Elliott et al. [20] reported
that for the SF-36 physical and mental summary scores,
Cohen’s d = 0.14/0.13, respectively. For our study, we as-
sume a medium Cohen’s d = 0.5 for our primary outcome,
which is between these ‘extreme values’.
With a statistical power of 90% and a significance level
of 0.05, we need n = 172 patients at T2 for two-sided
tests. Assuming a 40% drop-out rate [24] and 30% mor-
tality [25], 290 patients are needed at T1.
Data collection
Patients will be recruited from 20 ICUs in nine study cen-
ters across Germany (see Additional file 1). Eligible survi-
vors of severe sepsis or septic shock are screened on a daily
basis by ICU consultants and reported to the study team.
Within one month after discharge from ICU, patients are
contacted by a study physician and asked to participate in
the study. For eligibility, a cognition test is performed [26].
All patients are informed about the study course.
Within one month after discharge from ICU, the first
data set (T1) is collected by the study nurse, including
clinical and socio-demographic characteristics. At the
same time, the liaison physician contacts the respon-
sible general practitioner (GP) by telephone to ask for
study participation.
Randomization
Given the GP’s written consent, patients are randomized
in the intervention versus control group with n = 145 pa-
tients per group. Randomization sequence is computer-
generated and provided in a sealed opaque envelope.
Inclusion criteria
Patients are eligible on the presence of severe sepsis or
septic shock, as defined by the definitions of the German
Sepsis Society [27]. Two systemic inflammatory response
syndrome (SIRS) criteria have to be completed and at least
one organ dysfunction (see Additional file 2). Inclusion
criteria are checked by the participating ICU doctors.
Furthermore, patients must be 18 years or older and
capable of sufficient German language skills.
Exclusion criteria
Patients are excluded from study participation due to in-
sufficient German language skills, deafness, blindness or
speech impairment. Furthermore, patients suffering from
severe cognitive impairment are not eligible for study
participation (determined by a telephone interview of
cognitive status (TICS-M) ≤27 points) [26].
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Intervention treatment
The intervention contains three main components:
1. Discharge management with structured information
between inpatient and outpatient care in accordance
with the transitional care model [28], which was
shown to reduce costs and rehospitalization rates [29].
2. Training of GPs and patients in sepsis sequelae and
evidence-based treatment options [30]. A special
focus lies on an effective self-management of
patients, which improves health-related quality of
life in post-intensive care patients [31].
3. Monthly telephone monitoring of patients through
specifically designed telephone interviews is
provided for 12 months regarding sepsis sequelae
symptoms. Systematic monitoring improves the
physician-patient interaction and supplies relevant
information on patient clinical status to the GP,
according to the chronic care model [32,33].
The intervention is delivered by a study center-based
case manager and a liaison physician (see Figure 1). The
case manager is a nurse by qualification, trained in sepsis
aftercare. She acts as an attendant for the patient, asking
about the patient’s health constitution and actual prob-
lems, and provides training and monitoring. The liaison
physician as the GP’s contact person is responsible for
the education and reporting of the monitoring results
and offers feedback if required. The liaison physician
also determines further patient educational elements to
the case manager.
After discharge from the ICU, intervention patients re-
ceive specific discharge forms from the case manager. All
treating physicians (ICU, general wards and rehabilitation
clinic) are requested to record sepsis-related clinical and
social information about the patients and his or her needs.
This supports the GP to manage ambulant treatment and
special therapeutic needs of the patient like home care,
physiotherapy, specific adjuvants etcetera.
Both, patients and GPs are trained in evidence-based
diagnostics and therapy of the most prevalent sepsis se-
quelae. The liaison physician trains the GP face-to-face
using audiovisual education material to impart know-
ledge about etiology, symptoms, diagnostic instruments
and therapy options of sepsis sequelae.
Patients in the intervention group are educated as well
in a face-to-face situation by the case manager to get
better information about:
1. the study course,
2. the monitoring program,
3. origin and therapy of sepsis,
4. possible sepsis sequelae,
5. physical and psychological impacts of intensive
therapy and
6. coping strategies and self-efficacy.
Patients and GPs receive a written manual, including
both training content and monitoring instruments. Man-
uals are used to support training sessions. The patient
manual is based on the Discern-criteria [34]. Patients are
contacted every month during the first six months after
discharge from ICU and every three months during
months 7 to 12 for the monitoring. This telephone inter-
view includes established short form instruments for the
most common sepsis sequelae, differing from outcome
instruments (see Additional file 3). Based on the moni-
toring results, patients are encouraged to work toward
target agreements in daily life. Patient compliance is re-
quested and monitored in the course.
Figure 1 Players of the intervention.
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The liaison physician provides this information to the
GP with the help of a stratification of urgency (traffic light
scheme). The GP is contacted immediately by phone if a
new clinical condition arises and gets information about
diagnostic and therapeutic possibilities, whereas the liaison
physician is available for supervision and requests. In
addition, the patient is asked to visit his/her GP if health
problems occur.
Control treatment
Patients in the control group are treated as usual by
their GPs or ambulant specialists without any additional
information or monitoring. There aren’t any outpatient
sepsis follow-up clinics in Germany.
Due to the lack of sepsis aftercare guidelines in Germany,
there is no treatment standard available. Usual care is
assessed in control group patients. Qualitative interviews of
GPs and patients provide additional information.
Data collection
Data are collected from patients in questionnaires by
trained study staff, initially face to face, and from T2 on-
wards, by phone call. In addition, GPs and ICU staff are
asked to provide clinical information after patients have
given their informed and written consent. Data are docu-
mented as written case report forms and stored in a pro-
tected cabinet.
Outcome measures
Measurements take place from 3 months before hos-
pitalization (T-1, retrospectively) until 1, 6, 12 and
24 months after discharge from the ICU (T1-4).
Primary outcome is the health-related quality of life
assessed by the Short Form 36 Health Questionnaire (SF-
36), a multidimensional construction of physical, mental,
social and behavior-related components of well-being and
operational capability, validated also for German primary
care [35].
Secondary outcomes focus on the most relevant sepsis
sequelae, including the assessment of physical activity,
level of pain, and cognitive deficits or neuropathic symp-
toms by established questionnaires, all of which are
patient-reported outcomes.
Furthermore, for GP compliance review, treatment and
cost-effectiveness analysis, patient rehospitalizations, medi-
cation, care needs, mortality, physical therapy and ins-
trumental diagnostic procedures are documented by the
primary care provider. GPs are asked to provide details of
their practice characteristics.
For clinical analysis, diagnoses and ICU procedures
are extracted from the ICU documentation system.
For detailed variable/outcome parameter descriptions
see Table 1 and Additional file 4.
To gain insight into processes, barriers and mechanisms
of the intervention, qualitative interviews with patients
and GPs are performed on a subsample. In this context,
the roles of patients’ relatives are also to be evaluated.
Data analysis
Randomization process will be proofed using binary logis-
tic regression. The dependent variable logarithmic odds
ratio of patient is in the intervention versus control group.
As predictors, we use potential confounders (for example,
socio-demographic or clinical variables). Primary outcome
will be analyzed based on a two-sided t-test. Secondary
endpoints will be analyzed depending on scale level, using
descriptive or hypothesis generating test procedures. For
evaluation of average treatment effects, we will analyze the
outcome variables with a generalized analysis of covari-
ance (g-ANCOVA) and control for potential confounders.
Based on these results, we are able to adjust means, which
are comparable with outcome means of a perfect random-
ized and balanced design [49,50].
Furthermore, mortality is taken into account. Using sur-
vival analysis models, we are able to examine the relation-
ship between mortality and treatment. In this way, we also
try to identify mortality risk factors.
Finally, we plan cost-effectiveness analyses. Therefore, we
sum up the costs of micro interventions and compare the
averages of treatment and control group using g-ANCOVA
(see above).
Description of risks
Showing 6- month mortality of more than 30% [25], severe
sepsis ranks among critical long-term conditions. Serious
risks or undesired effects of completing questionnaires
have not been reported by clinical expertise of the scientific
experts in the advisory board of the study (see Additional
file 1). There are no specific risks related to the interven-
tion. Thus, there are no rules for stopping the intervention.
Ethical principles
The study is planned and conducted in accordance with
medical professional codex and the Helsinki Declaration of
1996 as well as the Federal Data Protection Act (BDSG).
Patients participate in the study voluntarily and give
written informed consent. Patients are informed that they
can cancel their participation at any time without disclos-
ing reasons for their cancellation and without negative
consequences for their future medical care. The study
protocol was approved by the institutional review board of
the University of Jena, 26 January 2011 (No.3001/111).
Data security
The patient names and other confidential information are
secured by the medical confidentiality rules and are treated
according to Federal Data Protection Act (BDSG).
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All study-related data and documents are stored on a
protected central server at Jena University Hospital. Only
members of the study team have access to the study files.
Intermediate and final reports are stored in the office
of the Institute of General Practice and Family Medicine
at the Jena University Hospital.
Discussion
Limitations
Contacting control patients via phone calls for data
collection may create a small intervention (Hawthorne)
effect in the control group. Therefore, the intervention
effect is likely to be underestimated. This might be
Table 1 List of variables/outcome parameters
Variables Time of measurement Instrument used (number of items)
Intensive care unit (ICU)
Documentation
ICU stay T1 Days
Mechanical ventilation T1 Days
Kidney replacement therapy T1 Days
Diagnoses at ICU discharge T1 ICD-10
Focus of infection T1 schematized (13)
Microbiological analysis T1 pathogen cluster (8)
Use of sedatives, steroids T1 schematized (4)
Patient reported
Educational status T1 schematized (2)
Socio-economic status T-1 to 4 schematized (8)
Outcome measure (patient ratings)
Health-related quality of life T-1 to 4 Short Form 36 Health Survey (SF-36) (36) [35]
Depressive symptoms T1 to 4 Major Depression Inventory (MDI) (12) [36]
Post-traumatic symptoms T1 to 4 Post-Traumatic Stress Syndrome 10-Questions Inventory (PTSS-10) (10) [37]
Motoric function T2 to 4 Short Musculoskeletal Function (XSMFA-D) (16) [38]
Impairment of swallowing, hearing, smelling T-1 to 4 4-stepped Likert scale (4)
Chronic pain T1 to 4 Graded Chronic Pain scale (GCPS) (7) [39]
Neuropathic symptoms T1 to 4 Neuropathic Symptom Score (NSS) (6) [40]
Nutritional status T-1 to 4 Malnutrition Universal Screening Tool (MUST) (4) [41]
Cognitive status T1 to 4 Telephone Interview of Cognitive Status (TICS-M) (21) [42,43]
Sleep T2 to 4 Regensburg Insomnia Scale (RIS) (15) [44]
Medication addiction T2 to 4 Short form for medication use (KFM) (12) [45]
Patient assessment of care T-1, 2 to 4 Patient Assessment of Care for Chronic Conditions (PACIC) (20) [46,47]
Compliance/adherence T-1,2 to 4 Modified Morisky questionnaire (4) [48]
Activities of daily life T2 to 4 (Instrumental) Activities of daily life (ADL/IADL) (11)
General practitioner (GP) documentation
Mortality T2 to 4
Current diagnoses T-1,2 to 4 ICD-10
GP consultation T2 to 4 Number
Stay in hospital T2 to 4 Days
Inability to work T2 to 3 Days
Medication T-1, 2 to 4 agent, dosage
Stay in rehabilitation clinic T1 to 4 Days
Remedies and therapeutic aids T2 to 4 schematized (1)
Nursing level T2 to 4 schematized (2)
Contacts to specialists, diagnostic procedures T1 to 4 schematized (7)
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acceptable because we would not overuse any effect of
the trial.
In addition, contamination by information flow between
the intervention and control group cannot be excluded.
However, this risk seems to be minimized by the allocation
of one GP to one patient of either intervention or control
group. Most GPs in Germany practice alone.
Strengths/conclusion
To our knowledge, SMOOTH is the first study evaluating
the effects of a primary care-based intervention for pa-
tients after a critical illness, that is sepsis [16]. Using estab-
lished primary care structures, SMOOTH may provide a
cost-effective addition to sepsis aftercare. Furthermore,
considering the long-term impact of sepsis sequelae, 24-
month follow-up data will be provided, which are rarely
published and allow analysis of intervention sustainability.
As a further innovative element, an external medical con-
sultant in primary care (the liaison physician) might help
to support quality of care in primary care settings -
strengthening the GP as a reliable clinical partner for pa-
tients after critical illness.
Trial status
The first patient was included on 28 February 2011. Pa-
tient recruitment is ongoing but not completed.
Additional files
Additional file 1: Scientific advisory council and SMOOTH study
centres.
Additional file 2: SIRS/Sepsis Criteria.
Additional file 3: Monitoring instruments.
Additional file 4: Outcome instruments.
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